Related Experiment Video
Updated: Sep 5, 2025

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
Published on: June 13, 2018
Experiences Using a Multidisciplinary Model for Treating Injection Drug Use Associated Infections: A Qualitative
Nathanial S Nolan1, Emily Gleason2, Laura R Marks1
1Department of Medicine, Division of Infectious Diseases, St. Louis School of Medicine, Washington University, St. Louis, MO, United States.
A new hospital program improved care for people with opioid use disorder and infections. Patients reported better pain control and access to addiction treatment, though stigma and loss of freedom remain challenges.
Area of Science:
- Public Health
- Infectious Diseases
- Addiction Medicine
Background:
- Rising rates of injection drug use, associated infections, and overdose deaths in the US.
- Initiation of a hospital-based program in 2020 to treat opioid use disorder (OUD) in patients with invasive infections.
- Program goals included improving care outcomes, patient experience, and transition to long-term addiction treatment.
Purpose of the Study:
- To evaluate the impact of the hospital program on patient care experiences.
- To identify areas for program improvement from the patient's perspective.
Main Methods:
- Semi-structured interviews with 30 patients admitted with infectious complications of injection drug use.
- Patients were divided into two cohorts: those admitted before (n=14) and after (n=16) program implementation.
- Interviews were transcribed, coded for emergent themes, with limited chart review for descriptive statistics.
Main Results:
- Common hospitalization themes included inadequate pain control, access to medications for opioid use disorder (MOUD), loss of freedom, and stigma.
- Program participants reported significantly better pain control and access to MOUD.
- Many participants highlighted the benefits of receiving care from an interprofessional team.
Conclusions:
- Hospital care for patients with opioid use disorder and injection-related infections improved with an interprofessional team approach.
- Perceived stigma from healthcare personnel and loss of freedom remained persistent barriers to care.
- The program demonstrated positive impacts on patient experience and access to essential treatments.
More Related Videos
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
18:40Combined In vivo Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
Published on: October 16, 2014
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urinary Tract Infection IV: Nursing Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...